S9, a Novel Anticancer Agent, Exerts Its Anti-Proliferative Activity by Interfering with Both PI3K-Akt-mTOR Signaling and Microtubule Cytoskeleton
Chao Zhang(University of Alabama at Birmingham), Jian Ding(Yuxi Normal University)
Cited by 55
Related Papers
Inhibitor hijacking of Akt activation
|Nature Chemical Biology|2009|294
Targeting Epigenetic Crosstalk as a Therapeutic Strategy for EZH2-Aberrant Solid Tumors
|Cell|2018|271
Combinatorial efficacy achieved through two-point blockade within a signaling pathway-a chemical genetic approach.
|PubMed|2003|75
Structure-Guided Inhibitor Design Expands the Scope of Analog-Sensitive Kinase Technology
|ACS Chemical Biology|2013|59
<i>Grateloupia longifolia</i> polysaccharide inhibits angiogenesis by downregulating tissue factor expression in HMEC‐1 endothelial cells
|British Journal of Pharmacology|2006|50